At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02652 CF PHARMTECH
Trading 04-30 13:18:28
22.160
+0.460
+2.12%
High22.460Low21.320Vol233.00K
Open22.400D1 Closing21.700Amplitude5.25%
Mkt Cap9.11BTradable Cap6.69BTotal Shares411.00M
T/O5.14MT/O Rate0.08%Tradable Shares302.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
CF PHARMTECH (02652) Spends HK$83,000 on Share Buyback on April 28
Stock News  ·  04-28 20:27
CF PHARMTECH (02652) Spends HK$83,000 on Share Buyback on April 28
CF PharmTech repurchases 4,000 H-shares at HK$20.82 apiece, lifting treasury stock to 641,000 shares
Bulletin Express  ·  04-28 20:23
CF PharmTech repurchases 4,000 H-shares at HK$20.82 apiece, lifting treasury stock to 641,000 shares
CF PharmTech files HKEX next-day return, discloses buyback at HKD 20.82/share
Reuters  ·  04-28 20:21
CF PharmTech files HKEX next-day return, discloses buyback at HKD 20.82/share
CF PHARMTECH Shares Climb Over 5% on Key Clinical Milestone for In-House EBV Device
Stock News  ·  04-28 15:40
CF PHARMTECH Shares Climb Over 5% on Key Clinical Milestone for In-House EBV Device
CF PharmTech executes HK$0.11 million share buy-back; treasury stock rises to 637,000 shares
Bulletin Express  ·  04-27 18:23
CF PharmTech executes HK$0.11 million share buy-back; treasury stock rises to 637,000 shares
CF PHARMTECH (02652) Repurchases 5,500 Shares for HK$114,000 on April 27
Stock News  ·  04-27 18:18
CF PHARMTECH (02652) Repurchases 5,500 Shares for HK$114,000 on April 27
CF PHARMTECH (02652) Achieves Milestone with First Severe Emphysema Patient Completing Trial for Self-Developed Bronchial Valve
Stock News  ·  04-27
CF PHARMTECH (02652) Achieves Milestone with First Severe Emphysema Patient Completing Trial for Self-Developed Bronchial Valve
CF PharmTech repurchases 18,500 H-shares for HK$0.38 million; treasury stock climbs to 631,500 shares
Bulletin Express  ·  04-24
CF PharmTech repurchases 18,500 H-shares for HK$0.38 million; treasury stock climbs to 631,500 shares
CF PHARMTECH Repurchases Shares for HK$382,300
Stock News  ·  04-24
CF PHARMTECH Repurchases Shares for HK$382,300
CF PHARMTECH Repurchases Shares Valued at HK$348,200
Stock News  ·  04-23
CF PHARMTECH Repurchases Shares Valued at HK$348,200
CF PharmTech buys back HKD 0.35 million of shares, treasury stock rises to 613,000
Bulletin Express  ·  04-23
CF PharmTech buys back HKD 0.35 million of shares, treasury stock rises to 613,000
CF PHARMTECH (02652) Allocates HK$208,700 for Share Buyback on April 22
Stock News  ·  04-22
CF PHARMTECH (02652) Allocates HK$208,700 for Share Buyback on April 22
CF PHARMTECH Repurchases Shares Valued at HK$418,700
Stock News  ·  04-20
CF PHARMTECH Repurchases Shares Valued at HK$418,700
CF PharmTech buys back 18,500 H-shares for HK$0.42 million; treasury stock reaches 0.57 million shares
Bulletin Express  ·  04-20
CF PharmTech buys back 18,500 H-shares for HK$0.42 million; treasury stock reaches 0.57 million shares
CF Pharmtech files HKEX next-day return disclosing buyback at HKD 22.63/share
Reuters  ·  04-20
CF Pharmtech files HKEX next-day return disclosing buyback at HKD 22.63/share
CF PHARMTECH (02652) Spends HK$296,800 on Share Buyback of 13,000 Shares on April 9
Stock News  ·  04-09
CF PHARMTECH (02652) Spends HK$296,800 on Share Buyback of 13,000 Shares on April 9
How JD Health’s CF PharmTech Alliance and Equity Awards Strategy Will Impact JD Health (SEHK:6618) Investors
Simply Wall St.  ·  04-06
How JD Health’s CF PharmTech Alliance and Equity Awards Strategy Will Impact JD Health (SEHK:6618) Investors
CF PharmTech repurchases 20,000 H shares, treasury stock rises to 542,000
Bulletin Express  ·  04-02
CF PharmTech repurchases 20,000 H shares, treasury stock rises to 542,000
CF PHARMTECH (02652) Repurchases 20,000 Shares for HK$456,700 on April 2
Stock News  ·  04-02
CF PHARMTECH (02652) Repurchases 20,000 Shares for HK$456,700 on April 2
CF PharmTech repurchases 9,500 H-shares; outstanding share count slips 0.0031%
Bulletin Express  ·  03-31
CF PharmTech repurchases 9,500 H-shares; outstanding share count slips 0.0031%
No data available

Introduction

Company Name.
CF PHARMTECH
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
CF PharmTech Inc is a China-based company primarily focused on the research & development, manufacturing and commercialization of inhalation technologies and inhalation drugs. The Company’s product portfolio primarily focused on respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD) and allergic rhinitis. The Company's primary products include CF017, a budesonide suspension for inhalation targeting bronchial asthma, and CF018, an azelastine hydrochloride and fluticasone propionate nasal spray approved for allergic rhinitis. The Company mainly conducts its business in the domestic market.
Issue price:
--